ArticleOpen medicine (Warsaw, Poland)2016

MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression.

Lin Jingjing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.